Chronic hepatitis B: The therapeutic challenge

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 5, 1997, Pages 559-562

  Locarnini, Stephen A ^a   Newbold, John E ^b  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

CHRONIC HEPATITIS; COST BENEFIT ANALYSIS; DISEASE ACTIVITY; DISEASE CARRIER; DRUG EFFICACY; EDITORIAL; HALF LIFE TIME; HEPATITIS B; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LONG TERM CARE; MATHEMATICAL MODEL; VIRUS REPLICATION;

CHRONIC DISEASE; DNA, VIRAL; HEPATITIS B; HUMANS;

EID: 0031008740     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.5.559     Document Type: Editorial

References (29)

1. Kane, M. A. (1996). Global status of hepatitis B immunization. Lancet 348, 696.
2. Lok, A. S. F. (1994). Treatment of chronic hepatitis B. Journal of Viral Hepatitis 1, 105-24.
3. Carman, W. F., Jacyna, M. R., Hadziyannis, S., Karayiannis, P., McGarvey, M. J., Makris, A. et al. (1989). Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet ii, 588-91.
4. Hadziyannis, S. J. (1995). Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hepatitis Reviews 1, 7-36.
5. Shaw, T., Amor, P., Civitico, G., Boyd, M. & Locarnini, S. (1994). In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrobial Agents and Chemotherapy 38, 719-23.
6. Doong, S.-L., Tsai, C.-H., Schinazi, R. F., Liotta, D. C. & Cheng, Y. C. (1991). Inhibition of the replication of hepatitis B virus in vitro by 2′-3′-dideoxy-3′-thiacytidine and related analogues. Proceedings of the National Academy of Science of the USA 88, 8495-9.
7. Dienstag, J. L., Perrillo, R. P., Schiff, E. R., Bartholomew, M., Vicary, C. & Rubin, M. (1995). A preliminary trial of lamivudine for chronic hepatitis B infection. New England Journal of Medicine 333, 1657-61.
8. Main, J., Brown, J. L., Howells, C., Gatassini, R., Crossey, M., Karayiannis, P. et al. (1996). A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. Journal of Viral Hepatitis 3, 211-5.
9. Omata, M., Katsutaro, H. & Yokosuka, O. (1986). In vivo study of the mechanism of action of antiviral agents against hepadnavirus replication in the liver. Journal of Hepatology 3, Suppl., S49-S55.
10. Yokosuka, O., Omata, M., Imazeki, F., Okuda, K. & Summers, J. (1985). Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA. Hepatology 5, 728-34.
11. Locarnini, S. A., Civitico, G. M. & Newbold, J. E. (1996). Hepatitis B: new approaches for antiviral chemotherapy. Antiviral Chemistry and Chemotherapy 7, 53-64.
12. Mason, W. S., Cullen, J., Saputelli, J., Wu, T.-T., Liu, C., London, W. T. et al. (1994). Characterization of the antiviral effects of 2′-carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Hepatology 19, 398-411.
13. Luscombe, C., Pedersen, J., Uren, E. & Locarnini, S. (1996). Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic viral DNA, RNA, and protein expression. Hepatology 24, 766-73.
14. Averett, D. R. & Mason, W. S. (1995). Evaluation of drugs for antiviral activity against hepatitis B virus. Viral Hepatitis Reviews 1, 129-42.
15. Nowak, M. A., Bonhoeffer, S., Hill, A. M., Boehme, R., Thomas, H. C. & McDade, H. (1996). Viral dynamics in hepatitis B virus infection. Proceedings of the National Academy of Science of the USA 93, 4398-402.
16. Droet, J., Courouce-Pauty, A. M., Thevenoux, A. M., Soulier, J. B., Chanard, J., Vallée, G. et al. (1975). Kinetics of HBsAg in man. Biomedicine 22, 158-66.
17. Tencza, M. G. & Newbold, J. E. (1997). Heterogeneous response for a mammalian hepadnavirus infection to acyclovir: drug-arrested intermediates of minus-strand viral DNA synthesis are enveloped and secreted from infected cells as virion-like particles. Journal of Medical Virology, 51, 6-16.
18. Luscombe, C. A. & Locarnini, S. A. (1996). The mechanism of action of antiviral agents in chronic hepatitis B. Viral Hepatitis Reviews 2, 1-35.
19. Omata, M. (1990). Significance of extrahepatic replication of hepatitis B virus. Hepatology 12, 364-6.
20. Luscombe, C., Pedersen, J., Bowden, S. & Locarnini, S. (1994). Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy. Liver 14, 182-92.
21. Aye, T. T., Bartholomeusz, A., Shaw, T., Bowden, S., Breschkin, A., McMillan, J. et al. (1997). Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. Journal of Hepatology, 26, in press.
22. Ling, R., Mutimer, D., Ahmed, N., Boxall, E. H., Elias, E., Dusheiko, G. M. et al. (1996). Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 24, 711-3.
23. Bock, C. T., Schranz, P., Schroder, C. H. & Zentgraf, H. (1994). Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 8, 215-29.
24. Newbold, J. E., Xin, H., Tencza, M., Sherman, G., Dean, J., Bowden, S. et al. (1995). The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. Journal of Virology 60, 3350-7.
25. Civitico, G. M. & Locarnini, S. A. (1994). The half-life of duck hepatitis B virus supercoiled DMA in congenially infected primary hepatocyte cultures. Virology 203, 81-9.
26. Weissberg, J. I., Andres, L. L., Smith, G. I., Weick, S., Nichols, J. E., Garcia, G. et al. (1984). Survival in chronic hepatitis B: an analysis of 397 patients. Annals of Internal Medicine 101, 613-6.
27. Milich, D. R., Jones, J. E., Hughes, J. L., Price, J., Raney, A. K. & McLachlan, A. et al. (1990). Is a function of the secreted hepatitis B e antigen to induce immunological tolerance in utero? Proceedings of the National Academy of Science of the USA 87, 6599-603.
28. Guidotti, L. G., Guilhot, S. & Chisari, F. V. (1994). Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumour necrosis factor-dependent and -independent pathways. Journal of Virology 68, 1265-70.
29. Civitico, G., Shaw, T. & Locarnini, S. (1996). Interaction between ganciclovir and foscarnet as inhibitors of duck hepatitis B virus replication in vitro. Antimicrobial Agents and Chemotherapy 40, 1180-5.